Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Peritoneal Carcinomatosis, HIPEC

Paul Sugarbaker

MD

🏢MedStar Washington Hospital Center🌐USA

Director, Program in Peritoneal Surface Oncology

94
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Paul Sugarbaker is the founding pioneer of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies. He developed the surgical techniques and chemotherapy protocols that established peritoneal metastases as a potentially curable condition rather than an end-stage disease. Over four decades he performed over 2,500 HIPEC procedures and trained the majority of peritoneal surface oncology surgeons worldwide. His work transformed the treatment paradigm for pseudomyxoma peritonei, colorectal peritoneal metastases, and mesothelioma.

Share:

🧪Research Fields 研究领域

HIPEC
cytoreductive surgery
peritoneal metastases
colorectal cancer
pseudomyxoma peritonei

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 Paul Sugarbaker 的研究动态

Follow Paul Sugarbaker's research updates

留下邮箱,当我们发布与 Paul Sugarbaker(MedStar Washington Hospital Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment